Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2010
11/11/2010WO2010129055A1 8-aza tetracycline compounds
11/11/2010WO2010129048A2 Therapeutic compounds
11/11/2010WO2010128889A1 Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles
11/11/2010WO2010128156A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
11/11/2010WO2010127877A1 Novel compositions for treating pseudomonas infection
11/11/2010WO2010127704A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
11/11/2010WO2010127558A1 Substituted benzoyl urea compounds, preparation methods and uses thereof
11/11/2010WO2010127492A1 Recombinant bcg vaccine rbcg::xb
11/11/2010WO2010127443A1 Inhibitors of sialidase or sialidase-like enzymes
11/11/2010WO2010127400A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
11/11/2010WO2010101967A3 Phosphothiophene and phosphothiazole hcv polymerase inhibitors
11/11/2010WO2010097229A3 Amorphous salt of a macrocyclic inhibitor of hcv
11/11/2010WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors
11/11/2010WO2009009001A9 Crystalline pyridazine compound
11/11/2010US20100286386 Combinatorial production of nucleotide and nucleoside (XiTP) analogues
11/11/2010US20100286384 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
11/11/2010US20100286270 Compositions For The Treatment Of Hoof Diseases
11/11/2010US20100286263 Gallium complexes with polyalcohols and methods of use
11/11/2010US20100286251 Mammalian Genes Involved In Viral Infection And Tumor Suppression
11/11/2010US20100286240 MicroRNAs FOR INHIBITING VIRAL REPLICATION
11/11/2010US20100286238 Suppression of viruses involved in respiratory infection or disease
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286234 Pharmaceutical Composition Comprising Anti-Mirna Antisense Oligonucleotides
11/11/2010US20100286227 Compounds from Mycelium of Antrodia Cinnamomea and Use Thereof
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286220 HNF4alpha ANTAGONISTS AND METHODS OF USE
11/11/2010US20100286216 Composition having a high osmotic activity and exhibiting antimicrobial, anti-inflammatory, and regenerative effects
11/11/2010US20100286212 Treating and Preventing Viral Infections
11/11/2010US20100286211 Oxazolidinone derivatives as antimicrobials
11/11/2010US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide
11/11/2010US20100286198 Biofilm-Inhibiting Effect and Anti-Infective Activity of N,C- Linked Arylisoquinolines and the Use Thereof
11/11/2010US20100286196 New inhibitor of dd-peptidase and its use as antibiotic or anticancer drug
11/11/2010US20100286192 Non-nucleoside reverse transcriptase inhibitors
11/11/2010US20100286185 HCV NS3 Protease Inhibitors
11/11/2010US20100286181 Pyrrole derivatives with antibacterial activity
11/11/2010US20100286169 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds
11/11/2010US20100286162 Human papilloma virus inhibitors and pharmaceutical compositions containing same
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286130 Antimicrobial compounds, their synthesis and their use for treatment of mammalian infections
11/11/2010US20100286125 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
11/11/2010US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/11/2010US20100286095 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
11/11/2010US20100286092 Beta-lactamase inhibitors
11/11/2010US20100286091 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
11/11/2010US20100286089 Process for the Preparation of Entecavir and Novel Intermediates Thereof Via Carbon-Silicon Oxidation
11/11/2010US20100286083 Nucleoside analogs
11/11/2010US20100286082 Riboswitches and methods and compositions for use of and with riboswitches
11/11/2010US20100286081 5-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] pyrimidin-2-oce salts and crystalline forms
11/11/2010US20100286079 Composition comprising covalent conjugates of chitosan and an acidic drug and parenteral administration
11/11/2010US20100286077 Compounds
11/11/2010US20100286070 Affinity tag
11/11/2010US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions
11/11/2010US20100286033 New cyclic peptide compounds
11/11/2010US20100286032 Prodrugs of hiv protease inhibitors
11/11/2010US20100286031 Antibiotic Formulations, Unit Doses, Kits and Methods
11/11/2010US20100286029 Use of a peptide as a therapeutic agent
11/11/2010US20100286028 Use of a peptide as a therapeutic agent
11/11/2010US20100286027 Anti-bacterial compositions
11/11/2010US20100286026 Novel protein
11/11/2010US20100285457 High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS)
11/11/2010US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
11/11/2010US20100285444 HBV precore protein capable of forming particles
11/11/2010US20100285160 Anti-influenza viral composition containing bark or stem extract of alnus japonica
11/11/2010US20100285155 Cleanser composition and methods for using the same
11/11/2010US20100285151 Methods and compositions for treating conditions associated with infection and/or inflammation
11/11/2010US20100285150 Dental sterilizing water, method for producing the water, and device for producing the water
11/11/2010US20100285148 Oral care method and kit
11/11/2010US20100285139 Pharmaceutical composition for the prophylaxis and/or symptomatic treatment of cystic fibrosis
11/11/2010US20100285137 Antibiotic/bone morphogenic protein formulation and method of treatment
11/11/2010US20100285135 Nanoparticles For Use In Immunogenic Compositions
11/11/2010US20100285132 Immunotherapy compositions, method of making and method of use thereof
11/11/2010US20100285129 Novel agent for salting out active principles in dressings containing at least one of fatty substance
11/11/2010US20100285122 Tablets for combination therapy
11/11/2010US20100285116 Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells
11/11/2010US20100285115 Novel Antiretroviral Combination
11/11/2010US20100285109 Truncated secretory aspartyl proteinase 2
11/11/2010US20100285108 Method for therapeutic use
11/11/2010US20100285106 Multicomponent vaccine
11/11/2010US20100285097 Vaginal delivery system
11/11/2010US20100285096 Hygiene Article Having Calcium Sugar Phosphate
11/11/2010US20100285095 Hygiene Article Having Calcium Sugar Acid Salt
11/11/2010US20100285091 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers
11/11/2010US20100285084 Antimicrobial coatings for medical devices and methods for making and using them
11/11/2010US20100285070 Polynucleotides of haemophilus parasuis and its use
11/11/2010US20100285067 Interferon-beta production modulating listeria strains and methods for using same
11/11/2010US20100285063 Novel canine influenza virus and vaccine therefore
11/11/2010US20100285062 Combined mucosal and parenteral immunization against hiv
11/11/2010US20100285061 Dna vaccination protocols
11/11/2010US20100285056 Baculovirus-Based Vaccines
11/11/2010US20100285055 Activation of natural killer (NK) cells and methods of use
11/11/2010US20100285054 Antimicrobial Composition Comprising Fungal Extract, Process for Producing Fungal Extract and Method for Protecting Organisms
11/11/2010US20100285051 Vaccine
11/11/2010US20100285050 Compositions and Methods
11/11/2010US20100285048 Use of flagellin in the immunotherapy of yersinia pestis
11/11/2010US20100285047 Therapeutics and diagnostics for group a streptococci
11/11/2010US20100285041 Class A Oligonucleotides with Immunostimulatory Potency
11/11/2010US20100285030 Antibodies to Ox-2/Cd200 and Uses Thereof
11/11/2010US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
11/11/2010US20100285024 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
11/11/2010US20100285022 Anti-rsv g protein antibodies
1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 1798